ATRC AtriCure, Inc.

NASDAQ
$53.59

AtriCure, Inc. (ATRC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus ATRC's own trailing one-year pace, with 75% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 8 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
4 transactions
Purchases
$0
0 shares
Sales
$1.2M
21,252 shares
Net activity
-$1.2M
purchases less sales

How much of that selling was preplanned? 75% planned / 25% discretionary

10b5-1 plan sales $879.8K 3 transactions · 15,939 shares
Discretionary sales $288.1K 1 transaction · 5,313 shares

Largest single sale: $407.6K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Privitera Salvatore Chief Technical Officer Sell 10b5-1 4,519 $60.00 $271.1K 142,745 −3.1% of holding
GROVES REGINA E Director Sell 5,313 $54.22 $288.1K 34,546 −13.3% of holding
Privitera Salvatore Chief Technical Officer Sell 10b5-1 3,657 $55.00 $201.1K 147,264 −2.4% of holding
Privitera Salvatore Chief Technical Officer Sell 10b5-1 7,763 $52.50 $407.6K 150,921 −4.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.